申请人:Sankyo Company, Limited
公开号:US05616579A1
公开(公告)日:1997-04-01
Compounds of formula (I): ##STR1## [wherein: R.sup.1 is a cyclic amino group, or a dialkylamino group; R.sup.2 a group of formula --NHCHR.sup.3 R.sup.4 wherein R.sup.3 and R.sup.4 are each alkyl aryl or aralkyl, or together form a cycloalkyl group, or R.sup.2 is an aromatic heterocyclic group, or a group of formula --B--S(O).sub.m --R.sup.5 wherein R.sup.5 is a substituted alkyl group, or an aromatic heterocyclic group; B is an alkylene or alkylidene group; m is 0, 1 or 2; A is a group of formula --CH.dbd.CH-- or --(CH.sub.2).sub.n --, where n is 1, 2 or 3]; and salts thereof have valuable anti-ulcer activity.
式(I)的化合物:##STR1## [其中:R.sup.1是环氨基或二烷基氨基;R.sup.2是式--NHCHR.sup.3 R.sup.4的基团,其中R.sup.3和R.sup.4分别是烷基芳基或芳基烷基,或者一起形成环烷基基团,或者R.sup.2是芳香杂环基团,或者是式--B--S(O).sub.m --R.sup.5的基团,其中R.sup.5是取代烷基基团或芳香杂环基团;B是烷基或烷基亚基团;m为0、1或2;A是式--CH.dbd.CH--或--(CH.sub.2).sub.n --的基团,其中n为1、2或3];及其盐具有有价值的抗溃疡活性。